9
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      RESOLVIENDO UNA DE LAS PIEZAS DEL PUZLE: COVID-19 Y DIABETES TIPO 2 Translated title: SOLVING ONE OF THE PIECES OF THE PUZZLE: COVID-19 AND TYPE 2 DIABETES

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Resumen

          La eclosión de la pandemia por COVID-19 supone un reto de enormes dimensiones y, dada la gran presencia de diabetes mellitus tipo2 en la población actual, hace que sea un problema de salud en el que centrar nuestros esfuerzos para dar la mejor respuesta a nuestros pacientes, que son más vulnerables al desarrollo de la infección y candidatos a presentar cuadros clínicos más graves. Este documento pretende abordar la relación entre la infección por COVID-19 y la DM2. Para ello analizaremos brevemente qué datos epidemiológicos sustentan esta asociación y, posteriormente, se profundizará en los mecanismos fisiopatológicos que podrían conectar ambas enfermedades.

          Translated abstract

          The emergence of the COVID-19 pandemic represents an enormous challenge. Given the considerable presence of type 2 diabetes mellitus in the current population, the pandemic is a health issue that requires an effort to provide better responses to our patients who are more vulnerable to the onset of infection and who are candidates for presenting more severe symptoms. This document attempts to address the relationship between COVID-19 infection and type 2 diabetes mellitus. To this end, we will briefly analyse whether the epidemiological data support this association and, subsequently, go in depth on the pathophysiological mechanisms that might connect the two diseases.

          Related collections

          Author and article information

          Contributors
          Journal
          Rev Clin Esp
          Rev Clin Esp
          Revista Clinica Espanola
          Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI).
          0014-2565
          1578-1860
          18 May 2020
          18 May 2020
          Affiliations
          [1 ]Unidad de Lípidos y Arterioesclerosis, Hospital Universitario Reina Sofía/Universidad de Córdoba/ Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, España
          [2 ]CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, España
          [3 ]Unidad de Insuficiencia Cardíaca, Diabetes y Riesgo Vascular, Servicio de Medicina Interna. Hospital Universitario Juan Ramón Jiménez, Huelva, España
          [4 ]Servicio de Medicina Interna, Hospital Comarcal de Zafra, Zafra, Badajoz, España
          [5 ]Servicio de Medicina Interna, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga, Málaga, España
          Author notes
          [* ]Autor para correspondencia: pabloperez@ 123456uco.es
          Article
          S0014-2565(20)30135-1
          10.1016/j.rce.2020.05.003
          7231728
          319794dd-aea2-41cc-bea0-653fa8a7d70e
          © 2020 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved.

          Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

          History
          : 4 May 2020
          : 13 May 2020
          Categories
          Article

          diabetes mellitus tipo 2,covid-19,enzima convertidora de angiotensina 2,enzima dipeptidil peptidasa 4,inhibidores del cotransportador sodio-glucosa tipo 2,análogos del péptido similar al glucagón,type 2 diabetes mellitus,angiotensin-converting enzyme 2,dipeptidyl peptidase-4 enzyme,sodium-glucose cotransporter 2 inhibitors,glucagon-like peptide analogues

          Comments

          Comment on this article